Company: NUTR
Filing Date: 2025-03-25
Form Type: CORRESP
Source: 0001641172-25-000449
Chunk: 55

Company: NUSATRIP Inc
Filing Date: 2025-03-25
Form: CORRESP
Chunk 55
---
 find attractive, and which would complement our respective businesses. Our Controlling Stockholder may discourage, delay, or prevent a profitable investment opportunity before our Board of Directors or stockholders and subsequently decide to pursue investment opportunities or take business opportunities for itself, which would prevent us from taking advantage of those opportunities. These actions may be taken even if they are opposed by our other shareholders, including those who purchase Common Stock in this offering. |

Risks Related to Owning Our Common Stock and this Offering

There is a limited public market for our securities.

We cannot predict the extent to which investor interest
in us following this offering and our listing on Nasdaq will lead to the development of an active trading market or how liquid that trading
market might become. The lack of an active trading market may reduce the value of shares of our Common Stock and impair the ability of
our stockholders to sell their shares at the time or price at which they wish to sell them. An inactive trading market may also impair
our ability to raise capital by selling our Common Stock and may impair our ability to acquire or invest in other companies, products,
or technologies by using our Common Stock as consideration.

We may not be able to satisfy listing requirements of Nasdaq or maintain a listing of our common stock on Nasdaq.

If our common stock is listed on Nasdaq, we must meet
certain financial and liquidity criteria to maintain such listing. If we violate Nasdaq’s listing requirements, or if we fail to
meet any of Nasdaq’s listing standards, our common stock may be delisted. In addition, our board of directors may determine that
the cost of maintaining our listing on a national securities exchange outweighs the benefits of such listing. A delisting of our common
stock from Nasdaq may materially impair our stockholders’ ability to buy and sell our common stock and could have an adverse effect
on the market price of, and the efficiency of the trading market for, our common stock. The delisting of our common stock could significantly
impair our ability to raise capital and the value of your investment.

The requirements of being a public company with its Common Stock listed on Nasdaq may strain our resources and divert management’s attention.

We are subject to the reporting requirements of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Sarbanes-Oxley Act, and other applicable securities
rules and regulations. Compliance with these rules and regulations incurs substantial legal and financial compliance costs, makes some
activities